Journal of Regenerative MedicineISSN: 2325-9620

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Commentary, Jrgm Vol: 13 Issue: 5

Zebrafish and Salamanders: Model Organisms for Studying Regeneration

Robert Louis*

Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, USA

*Corresponding Author: Robert Louis
Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, USA
E-mail: louis.r@stjude.org

Received: 02-Sep-2024, Manuscript No. JRGM-24-148134
Editor assigned: 03-Sep-2024, PreQC No. JRGM-24-148134 (PQ)
Reviewed: 17-Sep-2024, QC No. JRGM-24-148134
Revised: 23-Sep-2024, Manuscript No. JRGM-24-148134 (R)
Published: 27-Sep-2024, DOI:10.4172/2325-9620.1000334

Citation: Louis R (2024) Zebrafish and Salamanders: Model Organisms for Studying Regeneration. J Regen Med 13:5.

Copyright: © 2024 Louis R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Introduction

Regeneration is a fascinating biological process where organisms replace or restore lost tissues, organs, or limbs. Among various model organisms used to study this phenomenon, zebrafish and salamanders stand out due to their remarkable regenerative abilities. These organisms provide invaluable insights into regenerative medicine, developmental biology, and tissue engineering [1].

Zebrafish (Danio rerio) are a popular model organism in regenerative research due to their exceptional regenerative capabilities. They can regenerate a wide array of tissues, including fins, heart, spinal cord, and even parts of their eyes. The zebrafish's ability to regenerate heart tissue is particularly notable. Unlike mammals, which form scar tissue after cardiac injury, zebrafish can restore heart function by regenerating lost cardiomyocytes [2].

Zebrafish regeneration involves a series of genetic and molecular events that have been extensively studied. Key to this process is the activation of signaling pathways such as Wnt, Fgf, and Notch. These pathways coordinate cell proliferation, differentiation, and tissue patterning during regeneration. Recent studies have highlighted the role of specific genes, such as hand2 and fgf20a, in guiding the regenerative process, providing insights into potential therapeutic targets for human regenerative medicine [3].

Salamanders, particularly the axolotl (Ambystoma mexicanum), are renowned for their extraordinary limb regeneration abilities. Unlike zebrafish, axolotls can regenerate entire limbs, including bones, muscles, nerves, and skin. This capability makes them an ideal model for studying complex regenerative processes and understanding the cellular and molecular mechanisms involved in limb regeneration [4].

Limb regeneration in salamanders involves several distinct stages: wound healing, blastema formation, and tissue patterning. After an amputation, the wound heals rapidly, and a blastema—a mass of undifferentiated cells—forms at the site of injury. These cells proliferate and differentiate into various tissue types, restoring the missing limb structures. The interplay between signaling pathways, such as the Retinoic Acid and Wnt pathways, orchestrates this complex regenerative process [5].

Comparing zebrafish and salamanders reveals both similarities and differences in their regenerative strategies. Both organisms rely on similar signaling pathways, but the outcomes and specific mechanisms can differ. For instance, while zebrafish regenerate tissues by reprogramming existing cells, salamanders use a more pronounced de-differentiation process, where mature cells revert to a more primitive state before redifferentiating into new tissues [6].

The study of regeneration in zebrafish and salamanders provides crucial insights into human regenerative medicine. By understanding the genetic and molecular mechanisms underlying regeneration in these model organisms, researchers aim to develop therapies for conditions like heart disease, spinal cord injuries, and limb loss in humans. For example, identifying the key genes involved in zebrafish heart regeneration has led to promising avenues for developing cardiac repair strategies [7].

Despite significant progress, several challenges remain in leveraging regenerative insights from zebrafish and salamanders for human applications. One major challenge is translating findings from these model organisms to humans, given the differences in regenerative capabilities and underlying biology. Future research will need to focus on overcoming these translational barriers, refining gene-editing techniques, and exploring ways to enhance regenerative responses in human tissues [8].

Recent technological advances, such as CRISPR/Cas9 gene editing and advanced imaging techniques, have accelerated regenerative research using zebrafish and salamanders. These tools allow for precise manipulation of genes and real-time visualization of regenerative processes, providing deeper insights into the mechanisms of regeneration and facilitating the development of novel therapeutic approaches [9].

Integrating findings from zebrafish and salamander studies with research on other model systems, including mice and humans, is essential for a comprehensive understanding of regeneration. Comparative studies across different species can reveal conserved and divergent mechanisms, enhancing our overall knowledge of regenerative biology and informing the design of more effective regenerative therapies [10].

Conclusion

Zebrafish and salamanders offer powerful models for studying regeneration due to their unique abilities and the insights they provide into fundamental biological processes. Continued research on these organisms holds promise for advancing regenerative medicine and developing new treatments for a range of conditions. By exploring the regenerative capabilities of these model organisms, scientists can unlock new potential for repairing and restoring damaged tissues in humans, ultimately improving health outcomes and quality of life. Understanding and harnessing the regenerative potential of zebrafish and salamanders not only advances basic science but also paves the way for innovative therapeutic strategies, making them invaluable tools in the quest to overcome limitations in human regeneration.

References

  1. Barenholz Y (2012) Doxil®-the first FDA-approved nano-drug: Lessons learned. J Control Release;160(2):117-34..
  2. Indexed at, Google Scholar, Cross Ref

  3. Boateng F, Ngwa W (2019) Delivery of nanoparticle-based radiosensitizers for radiotherapy applications. Int J Mol Sci 2019;21(1):273.
  4. Indexed at, Google Scholar, Cross Ref

  5. Chen Y, Li Z H, Pan P, Zeng R Y, Zhang X Z (2021) Tumor-specific ONOO(-) nanogenerator for improved drug delivery and enhanced chemotherapy of tumor. ACS Nano;15(7):11514-25.
  6. Indexed at, Google Scholar, Cross Ref

  7. Chu D, Dong X, Shi X, Zhang C, Wang Z (2018) Neutrophil-based drug delivery systems. Adv Mater;30(22):1706245.
  8. Indexed at, Google Scholar, Cross Ref

  9. Deng Y, Yang F, Cocco E, Song E, Zhang J, et al. (2016) Improved i.p. drug delivery with bioadhesive nanoparticles. Proc Natl Acad Sci USA 2016;113(41):11453-8.
  10. Indexed at, Google Scholar, Cross Ref

  11. Akhurst, R. J. (2017) Targeting TGF-beta signaling for therapeutic gain. Cold Spring Harb Perspect Biol 2017;9(10):a022301.
  12. Indexed at, Google Scholar, Cross Ref

  13. Andzinski L, Kasnitz N, Stahnke S, Wu C F, Gereke M, et al. (2016) Type IIFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human. Int J Cancer;138(8):1982-93.
  14. Indexed at, Google Scholar, Cross Ref

  15. Bao, Y., and Cao, X. (2011) Revisiting the protective and pathogenic roles of neutrophils: Ly-6G is key!. Eur J Immunol;41(9):2535-8.
  16. Indexed at, Google Scholar, Cross Ref

  17. Brown M H, Dustin M L (2019) Steering CAR T cells into solid tumors. N Engl J Med;380(3):289-91.
  18. Indexed at, Google Scholar, Cross Ref

  19. Advani R., Flinn I, Popplewell L, Forero A, Bartlett N L, et al. (2018) CD47 blockade by Hu5F9-G4 and rituximab in non-Hodgkin's lymphoma. N Engl J Med;379(18):1711-21.
  20. Indexed at, Google Scholar, Cross Ref

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination